Peer review process
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.
Read more about eLife’s peer review process.Editors
- Reviewing EditorTomohiro KurosakiThe University of Osaka, Osaka, Japan
- Senior EditorTadatsugu TaniguchiThe University of Tokyo, Tokyo, Japan
Reviewer #1 (Public review):
Summary:
In this manuscript, the authors reveal that the availability of extracellular asparagine (Asn) represents a metabolic vulnerability for the activation and differentiation of naive CD4+ T cells. To deplete extracellular Asn, they employed two orthogonal approaches: activating naive CD4+ T cells in either PEGylated asparaginase (PEG-AsnASE)-treated medium or custom-formulated RPMI medium specifically lacking Asn. Importantly, they demonstrate that Asn depletion not only impaired metabolic reprogramming associated with CD4+ T cell activation but also reduced CD4+ helper T cell lineage-specific cytokine production, thereby ameliorating the severity of experimental autoimmune encephalomyelitis.
Strengths:
The experiments presented here are comprehensive and well-designed, providing compelling evidence for the conclusions. The conclusions will be important to the field.
Weaknesses:
(1) EAE is the prototypic T cell-mediated autoimmune disease model, and both Th1 and Th17 cells are implicated in its pathogenesis. In contrast, Th2 and Treg cells and their associated cytokines (such as IL-4 and IL-10) have been shown to play a role in the resolution of EAE, and potentially in the modulation of disease progression. Thus, it will be important to determine whether Asn depletion affects the differentiation of naive CD4+ T cells into corresponding subsets under Th2 and Treg polarization conditions, as well as the expression of lineage-specific transcription factors and cytokine production.
(2) EAE is characterized by inflammation and demyelination in the central nervous system (CNS), leading to neurological deficits. Myelin destruction is directly correlated with the severity of the disease. For Figure 6, did the authors perform spinal cord histological analysis by hematoxylin and eosin (H&E) or Luxol fast blue (LFB) staining? This is important to rigorously examine pathological EAE symptoms.
Reviewer #2 (Public review):
While the importance of asparagine in the differentiation and activation of CD8 T cells has been previously reported, its role in CD4 T cells remained unclear. Using culture media containing specific amino acids, the authors demonstrated that extracellular asparagine promotes CD4 T cell proliferation. Consistent with this, depletion of extracellular asparagine using PEG-AsnASE suppressed CD4 T cell activation. Proteomic analysis focusing on asparagine content revealed that, during the early phase of T cell activation, most asparagine incorporated into proteins is derived from extracellular sources. The authors further confirmed the importance of extracellular asparagine in vivo, demonstrating improved EAE pathology.
While the data are well organized and convincing, the mechanism by which asparagine deficiency leads to altered T cell differentiation remains unclear. It is also necessary to investigate the transporters involved in asparagine uptake. In particular, elucidating whether different T cell subsets utilize the same or distinct transport mechanisms would provide important insight into the immunoregulatory role of asparagine.
(1) The finding that asparagine supplementation promotes T cell proliferation under various amino acid conditions is highly significant. However, the concentration at which this effect occurs remains unclear. A titration analysis would be necessary to determine the dose-dependency of asparagine.
(2) The effects of asparagine deficiency occur during the early phase of T cell activation. Thus, it is likely that the transporters responsible for asparagine uptake are either rapidly induced upon activation or already expressed in the resting state. Since this is central to the focus of the manuscript, it is interesting to identify the transporter responsible for asparagine uptake during early T cell activation. A recent paper (DOI: 10.1126/sciadv.ads350) reported that macrophages utilize Slc6a14 to use extracellular asparagine. Is this also true for CD4+ T cells?
(3) Given that depletion of extracellular asparagine impairs differentiation of Th1 and Th17 cells, it is possible that TCR signaling is compromised under these conditions. This point should be investigated by targeting downstream signaling molecules such as Lck, ZAP70, or mTOR. Also, does it affect the protein stability of master transcription factors such as T-bet and RORgt?
(4) Is extracellular asparagine also important for the differentiation of helper T cell subsets other than Th1 and Th17, such as Th2, Th9, and iTreg?
(5) Asparagine taken up from outside the cell has been shown to be used for de novo protein synthesis (Figure 3E), but are there any proteins that are particularly susceptible to asparagine deficiency? This can be verified by performing proteome analysis, and the effects on Th1/17 subset differentiation mentioned above should also be examined.
(6) While the importance of extracellular asparagine is emphasized, Asns expression is markedly induced during early T cell activation. Nevertheless, the majority of asparagine incorporated into proteins appears to be derived from extracellular sources. Does genetic deletion of Asns have any impact on early CD4+ T cell activation? The authors indicated that newly synthesized Asns have little impact on CD8+ T cells in the Discussion section, but is this also true for CD4+ T cells? This could be verified through experiments using CRISPR-mediated Asns gene targeting or pharmacological inhibition.